Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer-Reference-Cited by-同舟云学术

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer

Published:2022-02-16 Issue:5 Volume:27 Page:850-862
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Moiseyenko Fedor V.^ORCID,Kuligina Ekaterina S.^ORCID,Zhabina Albina S.^ORCID,Belukhin Sergey A.^ORCID,Laidus Tatiana A.^ORCID,Martianov Aleksandr S.^ORCID,Zagorodnev Kirill A.,Sokolova Tatyana N.^ORCID,Chuinyshena Svetlana A.,Kholmatov Maxim M.^ORCID,Artemieva Elizaveta V.,Stepanova Ekaterina O.^ORCID,Shuginova Tatiana N.,Volkov Nikita M.^ORCID,Yanus Grigoriy A.^ORCID,Imyanitov Evgeny N.^ORCID

Funder

russian science foundation

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-022-02128-6.pdf

Reference62 articles.

1. Bettegowda C, Sausen M, Leary RJ et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra24. https://doi.org/10.1126/scitranslmed.3007094

2. Merker JD, Oxnard GR, Compton C et al (2018) Circulating tumor DNA analysis in patients with cancer: American society of clinical oncology and college of American pathologists joint review. J Clin Oncol 36(16):1631–1641. https://doi.org/10.1200/JCO.2017.76.8671

3. Gobbini E, Swalduz A, Levra MG et al (2020) Implementing ctDNA analysis in the clinic: challenges and opportunities in non-small cell lung cancer. Cancers (Basel) 12(11):3112. https://doi.org/10.3390/cancers12113112

4. Akhoundova D, Mosquera Martinez J et al (2020) The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer. J Clin Med 9(11):3674. https://doi.org/10.3390/jcm9113674

5. Charo LM, Eskander RN, Okamura R et al (2021) Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. Mol Oncol 15(1):67–79. https://doi.org/10.1002/1878-0261.12791

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of circulating plasma cell-free DNA for detection and quantification of brain arteriovenous malformations;Nano Today;2024-10